Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study

INTRODUCTION: The present study aimed to describe characteristics of patients with type 2 diabetes (T2D) in UK primary care initiated on dapagliflozin, post-dapagliflozin changes in glycated hemoglobin (HbA(1c)), body weight and blood pressure, and reasons for adding dapagliflozin to insulin. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilding, John, Bailey, Clifford, Rigney, Una, Blak, Betina, Beekman, Wendy, Emmas, Cathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118232/
https://www.ncbi.nlm.nih.gov/pubmed/27585582
http://dx.doi.org/10.1007/s13300-016-0193-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118232/
https://www.ncbi.nlm.nih.gov/pubmed/27585582
http://dx.doi.org/10.1007/s13300-016-0193-8

Ejemplares similares